N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide

C23H30BrN7O — CID 46914343

IUPACN'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide
SMILESCC(C)CN(NC(=O)Cc1ccc(CN2CCN(C)CC2)cc1)c1nc(C#N)ncc1Br
InChIInChI=1S/C23H30BrN7O/c1-17(2)15-31(23-20(24)14-26-21(13-25)27-23)28-22(32)12-18-4-6-19(7-5-18)16-30-10-8-29(3)9-11-30/h4-7,14,17H,8-12,15-16H2,1-3H3,(H,28,32)
InChIKeyGKHAGLDRXYRNFB-UHFFFAOYSA-N
MW500.45 g/mol
LogP2.59
Rot. Bonds8

About N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide

N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide (PubChem CID 46914343) has the molecular formula C23H30BrN7O and a molecular weight of 500.45 g/mol. Its IUPAC name is N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide.

Molecular Properties

Compound NameN'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide
PubChem CID46914343
Molecular FormulaC23H30BrN7O
Molecular Weight500.45 g/mol
Exact Mass499.17
IUPAC NameN'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide
SMILESCC(C)CN(NC(=O)Cc1ccc(CN2CCN(C)CC2)cc1)c1nc(C#N)ncc1Br
InChIInChI=1S/C23H30BrN7O/c1-17(2)15-31(23-20(24)14-26-21(13-25)27-23)28-22(32)12-18-4-6-19(7-5-18)16-30-10-8-29(3)9-11-30/h4-7,14,17H,8-12,15-16H2,1-3H3,(H,28,32)
InChIKeyGKHAGLDRXYRNFB-UHFFFAOYSA-N
XLogP2.59
TPSA88.39 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms32
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500500.45
LogP ≤ 52.59
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide?
The IUPAC name of N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide (CID 46914343) is N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide.
What is the SMILES notation for N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide?
The canonical SMILES for N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide is CC(C)CN(NC(=O)Cc1ccc(CN2CCN(C)CC2)cc1)c1nc(C#N)ncc1Br.
What is the InChIKey of N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide?
The InChIKey is GKHAGLDRXYRNFB-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H30BrN7O/c1-17(2)15-31(23-20(24)14-26-21(13-25)27-23)28-22(32)12-18-4-6-19(7-5-18)16-30-10-8-29(3)9-11-30/h4-7,14,17H,8-12,15-16H2,1-3H3,(H,28,32).
What are the key properties of N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide?
N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide has a molecular weight of 500.45 g/mol, XLogP of 2.59, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N'-(5-bromo-2-cyanopyrimidin-4-yl)-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-N'-(2-methylpropyl)acetohydrazide is sourced from PubChem (CID 46914343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).